iAnthus Capital Holdings, Inc.·Healthcare

NEW YORK and TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the fourth quarter and year ended December 31, 2025. The Company's Annual Report on Form 10-K (the “Annual Report”), which includes its audited consolidated financial statements for the year ended December 31, 2025 and the related management's discussion and analysis of financial condition and results of operations, can be accessed on the Securities and Exchange Commission's (“SEC's”) website at www.sec.gov, on the System for Electronic Document Analysis and Retrieval's (SEDAR+) website at www.sedarplus.com, and on the Company's website at www.iAnthus.com.

NEW YORK and TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, announces continued progress across its retail expansion, brand development and capital structure initiatives. In Florida, the Company plans to open its 26th GrowHealthy dispensary in Tequesta, FL, further expanding its footprint in a core market.
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.
Healthcare
Drug Manufacturers - Specialty & Generic
716
2018-03-02
-0.97